uterine artery embolization for treatment of symptomatic fibroids: a review of the evidence

fibroids are the most common benign tumors of the uterus during female reproductive age. uterine artery embolization (uae) using embolic particles (pva, gelfoam) to occlude the uterine arteries, have been reported as a relatively safe, effective, and durable nonsurgical alternative to hysterectomy in diminishing fibroid-related symptoms. to block the arterial blood supply to the fibroid completely, uae is typically performed in both uterine arteries by an experienced interventional radiologist. reduction in menorrhagia has been reported as 80-93 percent and the mean decrease in fibroid size varies from 50-78% in the literature. in our center improvement in menstrual bleeding after 6 months was 80.3%, and uterine fibroids underwent shrinkage of 63.7±33.7% after12 months. complication rate including amenorrhea ranges from 1% - 7% in the literature. uae may be followed by menopause in 1% of cases. nevertheless, it is usually encountered in women in their late 40s. it seems that the future of uae depends on optimal selection of patients according to volume-shrinkage prediction and fertility outcome. although pregnancy is possible after embolization, however neither fertility preservation nor improvement can be guaranteed following uae. indeed, women who desire to become pregnant should be cautioned about potential complications during pregnancy. the aim of this review is to discuss about the efficacy, safety, technique, and choice of embolic agent. also we present the effects of this technique on fertility and pregnancy outcome and also methods for dose reduction during this procedure.